Automated flow cytometry (FC) data analysis instruments for cell inhabitants identification and characterization are more and more getting used in tutorial, biotechnology, pharmaceutical, and scientific laboratories. The improvement of those computational strategies is designed to beat reproducibility and course of bottleneck points in handbook gating, nevertheless, the take-up of those instruments stays (anecdotally) low. Here, we carried out a complete literature survey of state-of-the-art computational instruments sometimes printed by analysis, scientific, and biomanufacturing laboratories for automated FC data analysis and recognized fashionable instruments based mostly on literature quotation counts.
Dimensionality discount strategies ranked extremely, reminiscent of generic t-distributed stochastic neighbor embedding (t-SNE) and its preliminary Matlab-based implementation for cytometry data viSNE. Software with graphical consumer interfaces additionally ranked extremely, together with PhenoGraph, SPADE1, FlowSOM, and Citrus, with unsupervised studying strategies outnumbering supervised studying strategies, and algorithm kind recognition unfold throughout Okay-Means, hierarchical, density-based, model-based, and different courses of clustering algorithms. Additionally, for example the precise use sometimes inside scientific areas alongside frequent citations, a survey issued by UK NEQAS Leucocyte Immunophenotyping to establish software utilization trends amongst scientific laboratories was accomplished.
The survey revealed 53% of laboratories haven’t but taken up automated cell inhabitants identification strategies, although amongst people who have, Infinicyt software is essentially the most often recognized. Survey respondents thought of data output high quality to be a very powerful issue when utilizing automated FC data analysis software, adopted by software velocity and degree of technical help. This overview discovered variations in software utilization between biomedical establishments, with instruments for discovery, data exploration, and visualization extra fashionable in academia, whereas automated instruments for specialised focused analysis that apply supervised studying strategies have been extra used in scientific settings.
Weighted Error Entropy-Based Information Theoretic Learning for Robust Subspace Representation
In a lot of the present illustration studying frameworks, the noise contaminating the data factors is usually assumed to be unbiased and identically distributed (i.i.d.), the place the Gaussian distribution is usually imposed. This assumption, although significantly simplifies the ensuing illustration issues, might not maintain in many sensible situations. For instance, the noise in face illustration is often attributable to native variation, random occlusion, and unconstrained illumination, which is actually structural, and therefore, doesn’t fulfill the i.i.d. property or the Gaussianity. In this text, we devise a generic noise mannequin, known as unbiased and piecewise identically distributed (i.p.i.d.) mannequin for sturdy presentation studying, the place the statistical conduct of the underlying noise is characterised utilizing a union of distributions.
We show that our proposed i.p.i.d. mannequin can higher describe the advanced noise encountered in sensible situations and accommodate the standard i.i.d. one as a particular case. Assisted by the proposed noise mannequin, we then develop a brand new information-theoretic studying framework for sturdy subspace illustration via a novel minimal weighted error entropy criterion. Thanks to the superior modeling functionality of the i.p.i.d. mannequin, our proposed studying technique achieves superior robustness towards varied varieties of noise. When making use of our scheme to the subspace clustering and picture recognition issues, we observe important efficiency beneficial properties over the present approaches.
Communication is a standard aspect in all medical consultations, affecting a variety of outcomes for medical doctors and sufferers. The rising demand for medical college students to be skilled to speak successfully has seen the emergence of interpersonal communication expertise as core graduate competencies in medical coaching around the globe. Medical colleges have adopted a variety of approaches to develop and consider these competencies. Â We included randomised managed trials (RCTs), cluster-RCTs (C-RCTs), and non-randomised managed trials (quasi-RCTs) evaluating the effectiveness of interventions delivered to college students in undergraduate or graduate-entry medical programmes.
We included research of interventions aiming to enhance medical college students’ interpersonal communication throughout medical consultations. Included interventions focused communication expertise related to empathy, relationship constructing, gathering info, and clarification and planning, in addition to particular communication duties reminiscent of listening, acceptable construction, and query model.
Integrated neighborhood case administration of childhood sickness in low- and middle-income nations
The main causes of mortality globally in kids youthful than 5 years of age (under-fives), and notably in the areas of sub-Saharan Africa (SSA) and Southern Asia, in 2018 have been infectious ailments, together with pneumonia (15%), diarrhoea (8%), malaria (5%) and new child sepsis (7%) (UNICEF 2019). Nutrition-related elements contributed to 45% of under-five deaths (UNICEF 2019). World Health Organization (WHO) and United Nations Children’s Fund (UNICEF), in collaboration with different improvement companions, have developed an strategy – now referred to as built-in neighborhood case administration (iCCM) – to deliver remedy providers for kids ‘nearer to house’.
Kappa Light chain Antibody |
46588-100ul |
SAB |
100ul |
EUR 302.4 |
Kappa Light chain Antibody |
E046588 |
EnoGene |
100μg/100μl |
EUR 255 |
Description: Available in various conjugation types. |
Kappa Light Chain Antibody |
V7424-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V7424-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V7424IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V7424SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
R20178-100UG |
NSJ Bioreagents |
100ug |
EUR 347.65 |
Description: This recombinant Human Kappa Light Chain antibody reacts to the kappa light chain of human immunoglobulins. No cross reactivity with lambda or mouse/rat/goat IgG. |
Kappa Light Chain Antibody |
R20178BTN-50UG |
NSJ Bioreagents |
50ug |
EUR 347.65 |
Description: This recombinant Human Kappa Light Chain antibody reacts to the kappa light chain of human immunoglobulins. No cross reactivity with the lambda light chain, mouse IgG, rat IgG, or goat IgG. |
Kappa Light Chain Antibody |
R20178SAF-250UG |
NSJ Bioreagents |
250ug |
EUR 832.15 |
Description: This recombinant Human Kappa Light Chain antibody reacts to the kappa light chain of human immunoglobulins. No cross reactivity with lambda or mouse/rat/goat IgG. |
Kappa Light Chain Antibody |
V3135-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. It recognizes human Ig kappa light chains of both secreted and cell surface immunoglobulin. It detects also free kappa light chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3135-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. It recognizes human Ig kappa light chains of both secreted and cell surface immunoglobulin. It detects also free kappa light chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3135IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. It recognizes human Ig kappa light chains of both secreted and cell surface immunoglobulin. It detects also free kappa light chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3135SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. It recognizes human Ig kappa light chains of both secreted and cell surface immunoglobulin. It detects also free kappa light chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3148-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3148-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3148IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3148SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3302-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3302-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3302SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3591-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3591-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3591IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3591SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3592-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3592-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3592IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3592SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3606-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3606-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3606IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3606SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3681-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3681-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3681IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3681SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3713-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3713-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3713IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3713SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V9030-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of kappa to lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V9030-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of kappa to lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V9030IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of kappa to lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V9030SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of kappa to lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V9031-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V9031-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V9031IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V9031SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3846-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3846-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3846SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3855-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3855-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V3855SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V7052-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V7052-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V7052IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V7052SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2624-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2624-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2624IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2624SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2145-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2145-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2145IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2145SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2146-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2146-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2146CF488-100T |
NSJ Bioreagents |
100 Tests |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2146IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2146SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2150-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2150-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2150CF488-100T |
NSJ Bioreagents |
100 Tests |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2150IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
V2150SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody is specific to the kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general, the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody |
RQ5072 |
NSJ Bioreagents |
100ul |
EUR 356.15 |
Description: The immunoglobulin light chain is the small polypeptide subunit of an antibody (immunoglobulin). A typical antibody is composed of two immunoglobulin (Ig) heavy chains and two Ig light chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. [Wiki] |
Kappa Light chain Antibody |
46588 |
SAB |
100ul |
EUR 319 |
Ig kappa Light Chain Antibody |
20-abx137077 |
Abbexa |
|
|
|
Kappa Light Chain (Kappa-IgLC) Antibody |
abx412052-1ml |
Abbexa |
1 ml |
EUR 526.8 |
|
Kappa Light Chain (Kappa-IgLC) Antibody |
abx411144-1mg |
Abbexa |
1 mg |
EUR 661.2 |
|
Kappa Light Chain (Kappa-IgLC) Antibody |
abx411421-1ml |
Abbexa |
1 ml |
EUR 526.8 |
|
Kappa Light Chain (Kappa-IgLC) Antibody |
abx411422-05mg |
Abbexa |
0.5 mg |
EUR 794.4 |
|
Kappa Light Chain (Kappa-IgLC) Antibody |
abx413125-1mg |
Abbexa |
1 mg |
EUR 994.8 |
|
Kappa Light Chain (Kappa-IgLC) Antibody |
abx415783-1mg |
Abbexa |
1 mg |
EUR 526.8 |
|
Kappa Light Chain (Kappa-IgLC) Antibody |
abx415786-05mg |
Abbexa |
0.5 mg |
EUR 477.6 |
|
Kappa Light Chain (Kappa-IgLC) Antibody |
abx415797-1mg |
Abbexa |
1 mg |
EUR 594 |
|
Kappa Light Chain (Kappa-IgLC) Antibody |
abx415799-05mg |
Abbexa |
0.5 mg |
EUR 477.6 |
|
Mouse Kappa Light Chain Antibody |
R20162-100UG |
NSJ Bioreagents |
100ug |
EUR 347.65 |
Description: This recombinant Mouse Kappa Light Chain antibody reacts to the kappa light chain of murine immunoglobulins. No cross reactivity with the lamda chain or human/rat/goat IgG. |
Mouse Kappa Light Chain Antibody |
R20162BTN-50UG |
NSJ Bioreagents |
50ug |
EUR 347.65 |
Description: This recombinant Mouse Kappa Light Chain antibody reacts to the kappa light chain of mouse immunoglobulins. No cross reactivity with the lamda light chain, human IgG, rat IgG, or goat IgG. |
Mouse Kappa Light Chain Antibody |
R20162SAF-250UG |
NSJ Bioreagents |
250ug |
EUR 832.15 |
Description: This recombinant Mouse Kappa Light Chain antibody reacts to the kappa light chain of murine immunoglobulins. No cross reactivity with the lamda chain or human/rat/goat IgG. |
Rabbit Kappa light chain antibody |
70R-10679 |
Fitzgerald |
1 ml |
EUR 447.6 |
Description: Rabbit polyclonal Kappa light chain antibody |
Kappa Light Chain Antibody Cocktail |
V3149-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody Cocktail |
V3149-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody Cocktail |
V3149IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain Antibody Cocktail |
V3149SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to kappa light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the kappa light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Kappa Light Chain (Kappa-IgLC) Antibody (AP) |
abx411146-1ml |
Abbexa |
1 ml |
EUR 678 |
|
Kappa Light Chain (Kappa-IgLC) Antibody (AP) |
abx411216-1ml |
Abbexa |
1 ml |
EUR 678 |
|
Kappa Light Chain(L1C1) Antibody |
BNCA0018-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Kappa Light Chain(L1C1), APC conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC810018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC810018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC800018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF680 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC800018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF680 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC940018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF594 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC940018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF594 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC880018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF488A conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC880018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF488A conjugate, Concentration: 0.1mg/mL |
kappa Light Chain (Free) Antibody |
abx021500-1mg |
Abbexa |
1 mg |
EUR 718.8 |
|
Kappa Light Chain(L1C1) Antibody |
BNC430018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF543 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC430018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF543 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC400018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF640R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC400018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF640R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC050018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF405M conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC050018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF405M conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNCB0018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), Biotin conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNCB0018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), Biotin conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNCAP0018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNCAP0018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNCR0018-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Kappa Light Chain(L1C1), RPE conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNUB0018-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), Concentration: 0.2mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNUB0018-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against Kappa Light Chain(L1C1), Concentration: 0.2mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNCP0018-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Kappa Light Chain(L1C1), PerCP conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNCH0018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNCH0018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNUM0018-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against Kappa Light Chain(L1C1), 1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC040018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF405S conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC040018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF405S conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC550018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF555 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC550018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF555 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC610018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF660R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC610018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF660R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC680018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF568 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC680018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF568 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC470018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF647 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC470018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF647 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC700018-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF770 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(L1C1) Antibody |
BNC700018-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(L1C1), CF770 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain (Kappa-IgLC) Antibody (HRP) |
abx411147-1ml |
Abbexa |
1 ml |
EUR 594 |
|
Kappa Light Chain (Kappa-IgLC) Antibody (RPE) |
abx411150-025mg |
Abbexa |
0.25 mg |
EUR 760.8 |
|
Kappa Light Chain (Kappa-IgLC) Antibody (RPE) |
abx411219-05mg |
Abbexa |
0.5 mg |
EUR 910.8 |
|
Kappa Light Chain (Kappa-IgLC) Antibody (HRP) |
abx413129-01mg |
Abbexa |
0.1 mg |
EUR 594 |
|
Kappa Light Chain (Kappa-IgLC) Antibody (HRP) |
abx415785-1ml |
Abbexa |
1 ml |
EUR 594 |
|
Kappa Light Chain (Kappa-IgLC) Antibody (HRP) |
abx415788-1ml |
Abbexa |
1 ml |
EUR 594 |
|
Kappa Light Chain (Kappa-IgLC) Antibody (RPE) |
abx415789-05ml |
Abbexa |
0.5 ml |
EUR 760.8 |
|
Kappa Light Chain (Kappa-IgLC) Antibody (HRP) |
abx414986-05mg |
Abbexa |
0.5 mg |
EUR 861.6 |
|
Kappa Light Chain (Kappa-IgLC) Antibody (HRP) |
abx412923-05mg |
Abbexa |
0.5 mg |
EUR 861.6 |
|
Kappa Light Chain (Kappa-IgLC) Antibody (FITC) |
abx411143-05mg |
Abbexa |
0.5 mg |
EUR 526.8 |
|
Kappa Light Chain (Kappa-IgLC) Antibody (FITC) |
abx415784-1mg |
Abbexa |
1 mg |
EUR 560.4 |
|
Kappa Light Chain(KLC264) Antibody |
BNCA0264-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Kappa Light Chain(KLC264), APC conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
BNCA0681-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Kappa Light Chain(HP6053), APC conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
BNCA0709-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Kappa Light Chain(KLC709), APC conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
BNC800264-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(KLC264), CF680 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
BNC800264-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(KLC264), CF680 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
BNC800681-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(HP6053), CF680 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
BNC800681-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(HP6053), CF680 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
BNC800709-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(KLC709), CF680 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
BNC800709-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(KLC709), CF680 conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
BNC810264-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(KLC264), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC264) Antibody |
BNC810264-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(KLC264), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
BNC810681-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(HP6053), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(HP6053) Antibody |
BNC810681-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Kappa Light Chain(HP6053), CF680R conjugate, Concentration: 0.1mg/mL |
Kappa Light Chain(KLC709) Antibody |
BNC810709-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Kappa Light Chain(KLC709), CF680R conjugate, Concentration: 0.1mg/mL |
The iCCM strategy offers built-in case administration providers for 2 or extra sicknesses – together with diarrhoea, pneumonia, malaria, extreme acute malnutrition or neonatal sepsis – amongst under-fives at neighborhood degree (i.e. exterior of healthcare services) by lay well being staff the place there may be restricted entry to well being facility-based case administration providers (WHO/UNICEF 2012). Â To assess the results of the built-in neighborhood case administration (iCCM) technique on protection of acceptable remedy for childhood sickness by an acceptable supplier, high quality of care, case load or severity of sickness at well being services, mortality, antagonistic occasions and protection of careseeking for kids youthful than 5 years of age in low- and middle-income nations.